Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance

Priya Uppuluri; Ashok Chaturvedi; Jose Lopez-Ribot
September 2009
Mycopathologia;Sep2009, Vol. 168 Issue 3, p101
Academic Journal
Abstract   Candida albicans biofilms on most medical devices are exposed to a flow of body fluids that provide water and nutrients to the fungal cells. While C. albicans biofilms grown in vitro under static conditions have been exhaustively studied, the same is not true for biofilms developed under continuous flow of replenishing nutrients. Here, we describe a simple flow biofilm (FB) model that can be built easily with materials commonly available in most microbiological laboratories. We demonstrate that C. albicans biofilms formed using this flow system show increased architectural complexity compared to biofilms grown under static conditions. C. albicans biofilms under continuous medium flow grow rapidly, and by 8 h show characteristics similar to 24 h statically grown biofilms. Biomass measurements and microscopic observations further revealed that after 24 h of incubation, FB was more than twofold thicker than biofilms grown under static conditions. Microscopic analyses revealed that the surface of these biofilms was extremely compact and wrinkled, unlike the open hyphal layer typically seen in 24 h static biofilms. Results of antifungal drug susceptibility tests showed that C. albicans cells in FB exhibited increased resistance to most clinically used antifungal agents.


Related Articles

  • Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. LaFleur, Michael D.; Lucumi, Edinson; Napper, Andrew D.; Diamond, Scott L.; Lewis, Kim // Journal of Antimicrobial Chemotherapy (JAC);Apr2011, Vol. 66 Issue 4, p820 

    Objectives: Microbial adhesion and biofilms have important implications for human health and disease. Candida albicans is an opportunistic pathogen which forms drug-resistant biofilms that contribute to the recalcitrance of disease. We have developed a high-throughput screen for...

  • Effects of Mentha suaveolens Essential Oil Alone or in Combination with Other Drugs in Candida albicans. Stringaro, Annarita; Vavala, Elisabetta; Colone, Marisa; Pepi, Federico; Mignogna, Giuseppina; Garzoli, Stefania; Cecchetti, Serena; Ragno, Rino; Angiolella, Letizia // Evidence-based Complementary & Alternative Medicine (eCAM);2014, Vol. 2014, p1 

    Candidosis is the most important cause of fungal infections in humans. The yeast Candida albicans can form biofilms, and it is known that microbial biofilms play an important role in human diseases and are very difficult to treat. The prolonged treatment with drugs has often resulted in failure...

  • Antifungal Carbazoles. Thevissen, Karin; Marchand, Arnaud; Chaltin, Patrick; Meert, Els M. K.; Cammue, Bruno P.A. // Current Medicinal Chemistry;Jun2009, Vol. 16 Issue 17, p2205 

    Carbazole derivatives are well known for their various pharmacological activities, including anti-HIV, anticancer, antibacterial and antifungal activities. This review will focus on carbazoles that possess antifungal activity against Candida albicans, the major human fungal pathogen. In our...

  • Amino Acid Residues Affecting Drug Pump Function in Candida albicans. Holmes, Ann R.; Tsao, Sarah; Lamping, Erwin; Niimi, Kyoko; Monk, Brian C.; Tanabe, Koichi; Niimi, Masakazu; Cannon, Richard D. // Japanese Journal of Medical Mycology;Dec2006, Vol. 47 Issue 4, p275 

    Membrane-located drug transporters are important components in the multidrug resistance of microbial cells and human tissues. In fungi, clinically important resistance to antifungal drugs most often results from the over-expression of efflux pump proteins in the plasma membrane of the resistant...

  • Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Nadeem, Sayyada Ghufrana; Hakim, Shazia Tabassum; Kazmi, Shahana Urooj // Libyan Journal of Medicine;Mar2010, Vol. 5 Issue 5, p1 

    Introduction: Identification of yeast isolated from clinical specimens to the species level has become increasingly important. Ever-increasing numbers of immuno-suppressed patients, a widening range of recognized pathogens, and the discovery of resistance to antifungal drugs are contributing...

  • Antifungals: Need to Search for a New Molecular Target. SANGAMWAR, A. T.; DESHPANDE, U. D.; PEKAMWAR, S. S. // Indian Journal of Pharmaceutical Sciences;2008, Vol. 70 Issue 4, p423 

    In the 1990s, drug resistance has become an important problem in a variety of infectious diseases including human immunodefi ciency virus infection, tuberculosis, and other bacterial infections which have profound effects on human health. At the same time, there have been dramatic increase in...

  • Prevalence of Candida dubliniensis Fungemia in Argentina: Identification by a Novel Multiplex PCR and Comparison of Different Phenotypic Methods. Bosco-Borgeat, Maria; Taverna, Constanza; Cordoba, Susana; Isla, Maria; Murisengo, Omar; Szusz, Wanda; Vivot, Walter; Davel, Graciela // Mycopathologia;Nov2011, Vol. 172 Issue 5, p407 

    Candida dubliniensis is an emerging pathogen that can cause invasive disease in patients who have a variety of clinical conditions. C. dubliniensis is often misidentified as Candida albicans by clinical laboratories. In Argentina, incidence data are still scarce, and only one systemic infection...

  • Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.  // Journal of Invasive Fungal Infections;2010, Vol. 4 Issue 3, p117 

    Fluconazole-resistant Candida spp. are increasingly incriminated in invasive Candida infections in cancer patients, including candidemia. In this study, patients with hematological malignancies were more likely to have been infected with non-albicans Candida isolates if they had received prior...

  • Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates. Carrillo-Muñoz, Alfonso Javier; Tur-Tur, Cristina; Hernández-Molina, Juan M.; Quindós, Guillermo; Marcos-Arias, Cristina; Eraso, Elena; Cárdenes, Delia; Ortiz-Maestro, Oscar; Santos, Patricia; Estivill, Dolors; Guardia, Celia; Giusiano, Gustavo // Revista Española de Quimioterapia;sep2010, Vol. 23 Issue 3, p122 

    The in vitro antifungal activity of posaconazole was tested against 315 yeast clinical isolates and 11 ATCC reference strains by means an agar diffusion method (Neosensitabs, Rosco, Denmark) based in CLSI M44-A2 document. Posaconazole activity was excellent against Cryptococcus and Rhodotorula...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics